Evaluating the Impact of a Training Program in Shared Decision-Making for Neurologists Treating People with Migraine.

Decisional conflict Headache Migraine Shared decision-making Spanish Training activity

Journal

Neurology and therapy
ISSN: 2193-8253
Titre abrégé: Neurol Ther
Pays: New Zealand
ID NLM: 101637818

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 08 03 2023
accepted: 09 05 2023
medline: 13 6 2023
pubmed: 13 6 2023
entrez: 13 6 2023
Statut: ppublish

Résumé

Migraine symptoms vary significantly between patients and within the same patient. Currently, an increasing number of therapeutic options are available for symptomatic and preventive treatment. Guidelines encourage physicians to use shared decision-making (SDM) in their practice, listening to patients' treatment preferences in order to select the most suitable and effective therapy. Although training for healthcare professionals could increase their awareness of SDM, results concerning its effectiveness are inconclusive. This study aimed to analyze the impact of a training activity to promote SDM in the context of migraine care. This was addressed by evaluating the impact on patients' decisional conflict (main objective), patient-physician relationship, neurologists' perceptions of the training and patient's perception of SDM. A multicenter observational study was conducted in four highly specialized headache units. The participating neurologists received SDM training targeting people with migraine in clinical practice to provide techniques and tools to optimize physician-patient interactions and encourage patient involvement in SDM. The study was set up in three consecutive phases: control phase, in which neurologists were blind to the training activity and performed the consultation with the control group under routine clinical practice; training phase, when the same neurologists participated in the SDM training; and SDM phase, in which these neurologists performed the consultation with the intervention group after the training. Patients in both groups with a change of treatment assessment during the visit completed the Decisional conflict scale (DCS) after the consultation to measure the patient's decisional conflict. Also, patients answered the patient-doctor relationship questionnaire (CREM-P) and the 9-item Shared Decision-Making Questionnaire (SDM-Q-9). The mean ± SD scores obtained from the study questionnaires were calculated for both groups and compared to determine whether there were significant differences (p < 0.05). A total of 180 migraine patients (86.7% female, mean age of 38.5 ± 12.3 years) were included, of which 128 required a migraine treatment change assessment during the consultation (control group, n = 68; intervention group, n = 60). A low decisional conflict was found without significant differences between the intervention (25.6 ± 23.4) and control group (22.1 ± 17.9; p = 0.5597). No significant differences in the CREM-P and SDM-Q-9 scores were observed between groups. Physicians were satisfied with the training and showed greater agreement with the clarity, quality and selection of the contents. Moreover, physicians felt confident communicating with patients after the training, and they applied the techniques and SDM strategies learned. SDM is a model currently being actively used in clinical practice for headache consultation, with high patient involvement in the process. This SDM training, while useful from the physician's perspective, may be more effective at other levels of care where there is still room for optimization of patient involvement in decision-making.

Identifiants

pubmed: 37310593
doi: 10.1007/s40120-023-00495-4
pii: 10.1007/s40120-023-00495-4
pmc: PMC10310651
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1319-1334

Informations de copyright

© 2023. The Author(s).

Références

Neurol Clin. 2019 Nov;37(4):631-649
pubmed: 31563224
Health Expect. 2015 Dec;18(6):2570-83
pubmed: 24975503
Med Decis Making. 1995 Jan-Mar;15(1):25-30
pubmed: 7898294
Psychooncology. 2012 Dec;21(12):1265-74
pubmed: 23208837
J Otolaryngol Head Neck Surg. 2018 Sep 3;47(1):52
pubmed: 30176947
J Gen Intern Med. 2006 Apr;21(4):360-2
pubmed: 16686813
Patient Educ Couns. 2012 Oct;89(1):122-8
pubmed: 22647558
Cephalalgia. 2011 Mar;31(4):463-70
pubmed: 20819843
Transl Behav Med. 2018 Nov 21;8(6):876-886
pubmed: 29982747
Patient Educ Couns. 2009 Oct;77(1):48-54
pubmed: 19403258
Med Decis Making. 2009 Jan-Feb;29(1):61-8
pubmed: 19196706
BMC Med Inform Decis Mak. 2013 Apr 17;13:50
pubmed: 23594514
BMC Med Inform Decis Mak. 2014 Nov 01;14:95
pubmed: 25361614
Patient Educ Couns. 2010 Jul;80(1):94-9
pubmed: 19879711
PLoS One. 2013 Jun 18;8(6):e66127
pubmed: 23823627
J Headache Pain. 2019 May 31;20(1):65
pubmed: 31151382
J Palliat Med. 2013 May;16(5):531-6
pubmed: 23621707
Patient Educ Couns. 2021 May;104(5):1229-1236
pubmed: 33248869
Ann Fam Med. 2013 Jul-Aug;11(4):315-23
pubmed: 23835817
Health Expect. 2017 Dec;20(6):1254-1263
pubmed: 28521082
Lancet. 2018 Mar 31;391(10127):1315-1330
pubmed: 29523342
World J Orthop. 2021 Dec 18;12(12):1026-1035
pubmed: 35036345
Dtsch Arztebl Int. 2015 Oct 2;112(40):672-9
pubmed: 26517595
BMJ Open. 2019 Jun 21;9(6):e026488
pubmed: 31230005
Int J Environ Res Public Health. 2021 Oct 23;18(21):
pubmed: 34769668
Patient Prefer Adherence. 2022 Jan 18;16:149-158
pubmed: 35082490
BMC Fam Pract. 2013 Sep 11;14:135
pubmed: 24024587
PLoS One. 2014 Jun 16;9(6):e98933
pubmed: 24932784
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2004 Oct;47(10):977-84
pubmed: 15490086
Ann Am Thorac Soc. 2015 Apr;12(4):520-5
pubmed: 25734699
Health Expect. 2015 Dec;18(6):2143-53
pubmed: 24593044
Value Health. 2021 Sep;24(9):1335-1342
pubmed: 34452714
J Telemed Telecare. 2006;12(8):410-5
pubmed: 17227607
Headache. 2007 Apr;47(4):540-5
pubmed: 17445103
Sci Rep. 2021 Apr 15;11(1):8286
pubmed: 33859216
Patient Prefer Adherence. 2022 Dec 15;16:3291-3302
pubmed: 36545540
Clin Rehabil. 2014 Jan;28(1):20-35
pubmed: 23858525
Lancet. 2021 Apr 17;397(10283):1505-1518
pubmed: 33773612
Acad Med. 2015 Feb;90(2):197-202
pubmed: 25354076
Actas Esp Psiquiatr. 2009 Mar-Apr;37(2):94-100
pubmed: 19401857
Patient Educ Couns. 2021 Mar;104(3):571-577
pubmed: 32962880
J Headache Pain. 2018 Feb 21;19(1):17
pubmed: 29468450
Neurology. 2000;55(9 Suppl 2):S46-52
pubmed: 11089519
Health Expect. 2015 Apr;18(2):210-20
pubmed: 23167846
JMIR Perioper Med. 2020 Apr 3;3(1):e15588
pubmed: 33393920
Headache. 2018 Jul;58(7):993-1006
pubmed: 29727478
Teach Learn Med. 2016;28(2):202-9
pubmed: 27064722
Headache. 2021 Jul;61(7):1021-1039
pubmed: 34160823
PLoS One. 2014 Oct 24;9(10):e110530
pubmed: 25343495
Cochrane Database Syst Rev. 2010 May 12;(5):CD006732
pubmed: 20464744

Auteurs

J Porta-Etessam (J)

Neurology Department, Hospital Clínico San Carlos, Madrid, Spain.

S Santos-Lasaosa (S)

Neurology Department, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.

J Rodríguez-Vico (J)

Neurology Department, Fundación Jiménez Díaz, Madrid, Spain.

M Núñez (M)

Eli Lilly, Madrid, Spain.

A Ciudad (A)

Eli Lilly, Madrid, Spain.

S Díaz-Cerezo (S)

Eli Lilly, Madrid, Spain.

M Comellas (M)

Outcomes'10, Castellón, Spain.

F J Pérez-Sádaba (FJ)

Outcomes'10, Castellón, Spain.

L Lizán (L)

Outcomes'10, Castellón, Spain. lizan@outcomes10.com.
Department of Medicine, Jaume I University, Av. Sos Baynat s/n, 12071, Castellón, Spain. lizan@outcomes10.com.

A L Guerrero-Peral (AL)

Headache Unit, Neurology Department, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.
Department of Medicine, University of Valladolid, Valladolid, Spain.

Classifications MeSH